• Alice Fabbri, Giorgia Gregoraci, Dario Tedesco, Filippo Ferretti, Francesco Gilardi, Diego Iemmi, Cosima Lisi, Angelo Lorusso, Francesca Natali, Edit Shahi, and Alessandro Rinaldi.
• Centre of Research in Medical Pharmacology, University of Insubria, Varese, Italy Department of Medical and Surgical Sciences, Centre for International Health, University of Bologna, Bologna, Italy.
• BMJ Open. 2016 Jun 1; 6 (6): e011124.

ObjectiveTo describe how Italian medical societies interact with pharmaceutical and medical device industries through an analysis of the information available on their websites.DesignCross sectional study.SettingItaly.Participants154 medical societies registered with the Italian Federation of Medical-Scientific Societies.Main Outcome MeasuresIndicators of industry sponsorship (presence of industry sponsorship in the programme of the last medical societies' annual conference; presence of manufacturers' logos on the homepage; presence of industry sponsorship of satellite symposia during the last annual conference).Results131 Italian medical societies were considered. Of these, 4.6% had an ethical code covering relationships with industry on their websites, while 45.6% had a statute that mentioned the issue of conflict of interest and 6.1% published the annual financial report. With regard to industry sponsorship, 64.9% received private sponsorship for their last conference, 29.0% had manufacturers' logos on their webpage, while 35.9% had industry-sponsored satellite symposia at their last conference. The presence of an ethical code on the societies' websites was associated with both an increased risk of industry sponsorship of the last conference (relative risk (RR) 1.22, 95% CIs 1.01 to 1.48 after adjustment) and of conferences and/or satellite symposia (RR 1.22, 95% CIs 1.02 to 1.48 after adjustment) but not with the presence of manufacturers' logos on the websites (RR 1.79, 95% CIs 0.66 to 4.82 after adjustment). No association was observed with the other indicators of governance and transparency.ConclusionsThis survey shows that industry sponsorship of Italian medical societies' conferences is common, while the presence of a structured regulatory system is not. Disclosure of the amount of industry funding to medical societies is scarce. The level of transparency therefore needs to be improved and the whole relationship between medical societies and industry should be further disciplined in order to avoid any potential for conflict of interest.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

17 keywords...

hide…